Cantor Fitzgerald Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
7/16/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Cantor FitzgeraldRaises TargetInfosys (INFY)Neutral -> Neutral$16.00 -> $19.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/13/2018Cantor FitzgeraldSet Price Targetbluebird bio (BLUE)Sell $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/13/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Neutral -> Hold$18.00 -> $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018Cantor FitzgeraldSet Price TargetGW Pharmaceuticals (GWPH)Buy $235.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/11/2018Cantor FitzgeraldSet Price TargetAurinia Pharmaceuticals (AUPH)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018Cantor FitzgeraldRaises TargetBiohaven Pharmaceutical (BHVN)Overweight -> Overweight$42.00 -> $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/11/2018Cantor FitzgeraldInitiatesGalmed Pharmaceuticals (GLMD)Buy $59.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/11/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Cantor FitzgeraldSet Price TargetEli Lilly And Co (LLY)Buy $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018Cantor FitzgeraldRaises TargetThe Ensign Group (ENSG)Overweight $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Cantor FitzgeraldReiteratesCerner (CERN)Overweight $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/2/2018Cantor FitzgeraldReiteratesMelinta Therapeutics (MLNT)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
7/5/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/5/2018Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $300.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/5/2018Cantor FitzgeraldReiteratesWellCare Health Plans (WCG)Overweight -> Overweight$235.00 -> $275.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/2/2018Cantor FitzgeraldInitiatesMarinus Pharmaceuticals (MRNS)Overweight $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/1/2018Cantor FitzgeraldInitiatesMelinta Therapeutics (MLNT)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018Cantor FitzgeraldRaises TargetAccenture (ACN)Overweight -> Overweight$180.00 -> $185.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/28/2018Cantor FitzgeraldReiteratesArsanis (ASNS)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/28/2018Cantor FitzgeraldSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $42.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018Cantor FitzgeraldReiteratesAquinox Pharmaceuticals (AQXP)Overweight -> NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018Cantor FitzgeraldRaises TargetGlobal Blood Therapeutics (GBT)Overweight -> Overweight$69.00 -> $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018Cantor FitzgeraldReiteratesApellis Pharmaceuticals (APLS)Buy $52.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/26/2018Cantor FitzgeraldReiteratesAldeyra Therapeutics (ALDX)Buy $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/26/2018Cantor FitzgeraldReiteratesFactSet Research Systems (FDS)Hold $203.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/24/2018Cantor FitzgeraldReiteratesExela Technologies (XELA)Buy $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/24/2018Cantor FitzgeraldReiteratesArray Biopharma (ARRY)Overweight -> Buy$24.00 -> $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/24/2018Cantor FitzgeraldReiteratesSynergy Pharmaceuticals (SGYP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018Cantor FitzgeraldReiteratesPerrigo (PRGO)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Cantor FitzgeraldReiteratesHeron Therapeutics (HRTX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Cantor FitzgeraldReiteratesMesoblast (MESO)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Cantor FitzgeraldReiteratesQuality Systems (QSII)Overweight -> Buy$21.00 -> $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/20/2018Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/15/2018Cantor FitzgeraldReiteratesEgalet (EGLT)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesOpiant Pharmaceuticals (OPNT)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesMomenta Pharmaceuticals (MNTA)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesEmergent Biosolutions (EBS)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesBiohaven Pharmaceutical (BHVN)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Cantor FitzgeraldReiteratesAcelRx Pharmaceuticals (ACRX)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018Cantor FitzgeraldReiteratesArrowhead Pharmaceuticals (ARWR)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018Cantor FitzgeraldRaises TargetCentene (CNC)Overweight $137.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/17/2018Cantor FitzgeraldReiteratesCytokinetics (CYTK)Hold $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/15/2018Cantor FitzgeraldReiteratesProthena (PRTA)Overweight -> Buy$14.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018Cantor FitzgeraldReiteratesFirst Data (FDC)Hold $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018Cantor FitzgeraldReiteratesStryker (SYK)Hold $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018Cantor FitzgeraldLowers TargetPolarityte (COOL)Overweight -> Buy$70.00 -> $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Overweight -> Buy$25.00 -> $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018Cantor FitzgeraldReiteratesIntegra Lifesciences (IART)Hold $59.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/12/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesEmergent Biosolutions (EBS)Buy $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesANI Pharmaceuticals Inc Common Stock (ANIP)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesBiohaven Pharmaceutical (BHVN)Buy $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesCollegium Pharmaceutical (COLL)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesEagle Pharmaceuticals (EGRX)Overweight $81.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesAcelRx Pharmaceuticals (ACRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesMomenta Pharmaceuticals (MNTA)Hold $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldInitiatesOpiant Pharmaceuticals (OPNT)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldSet Price TargetParatek Pharmaceuticals (PRTK)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldReiteratesSpero Therapeutics (SPRO)Buy $27.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Cantor FitzgeraldSet Price TargetRadius Health (RDUS)Buy $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018Cantor FitzgeraldReiteratesAllscripts Healthcare Solutions (MDRX)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Cantor FitzgeraldInitiatesPfizer (PFE)Overweight $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Cantor FitzgeraldInitiatesEli Lilly And Co (LLY)Overweight $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Cantor FitzgeraldReiteratesEvolus (EOLS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Cantor FitzgeraldRaises TargetJack Henry & Associates (JKHY)Overweight -> Overweight$132.00 -> $141.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Cantor FitzgeraldUpgradesbluebird bio (BLUE)Underweight -> OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $27.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018Cantor FitzgeraldRaises TargetTeladoc (TDOC)Neutral -> Neutral$35.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018Cantor FitzgeraldReiteratesCoupa Software (COUP)Overweight -> Buy$58.00 -> $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Cantor FitzgeraldReiteratesSabra Health Care REIT (SBRA)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Cantor FitzgeraldReiteratesHealthequity (HQY)Neutral -> Hold$65.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/3/2018Cantor FitzgeraldSet Price Targetbluebird bio (BLUE)Sell $122.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/3/2018Cantor FitzgeraldInitiatesVentas (VTR)Neutral $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018Cantor FitzgeraldSet Price TargetCelgene (CELG)Hold $112.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018Cantor FitzgeraldReiteratesSquare (SQ)Overweight -> Buy$51.00 -> $69.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesGlobus Medical (GMED)Overweight $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesOrthofix International (OFIX)Overweight $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesK2M Group (KTWO)Overweight $28.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesMazor Robotics (MZOR)Neutral $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesNuVasive (NUVA)Neutral $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldInitiatesSeaSpine (SPNE)Overweight $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldDowngradesQuality Systems (QSII)Overweight -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Cantor FitzgeraldSet Price TargetNabriva Therapeutics (NBRV)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Cantor FitzgeraldUpgradesQuality Systems (QSII)Neutral -> Overweight $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Cantor FitzgeraldDowngradesHealthequity (HQY)Overweight -> Neutral $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Cantor FitzgeraldReiteratesArrowhead Pharmaceuticals (ARWR)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/29/2018Cantor FitzgeraldReiteratesVirtusa (VRTU)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/29/2018Cantor FitzgeraldSet Price TargetRevance Therapeutics (RVNC)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/25/2018Cantor FitzgeraldReiteratesPaypal (PYPL)Overweight $93.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/25/2018Cantor FitzgeraldReiteratesDXC Technology (DXC)Neutral $97.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Cantor FitzgeraldSet Price TargetCelgene (CELG)Hold $112.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Cantor FitzgeraldSet Price TargetTheravance Biopharma (TBPH)Buy $55.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018Cantor FitzgeraldInitiatesApellis Pharmaceuticals (APLS)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018Cantor FitzgeraldDowngradesEgalet (EGLT)Overweight -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018Cantor FitzgeraldReiteratesJack Henry & Associates (JKHY)Buy $134.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/21/2018Cantor FitzgeraldSet Price TargetNabriva Therapeutics (NBRV)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/20/2018Cantor FitzgeraldSet Price TargetProgenics Pharmaceuticals (PGNX)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesbluebird bio (BLUE)UnderweightLowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Cantor FitzgeraldReiteratesCorium International (CORI)Buy $14.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Cantor FitzgeraldRaises TargeteHealth (EHTH)Overweight $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018Cantor FitzgeraldReiteratesCerner (CERN)Buy $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetAurinia Pharmaceuticals (AUPH)Buy $16.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesZoetis (ZTS)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesFive Star Senior Living (FVE)Overweight $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldReiteratesathenahealth (ATHN)Hold $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetValeant Pharmaceuticals (VRX)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetCidara Therapeutics (CDTX)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018Cantor FitzgeraldReiteratesViewray (VRAY)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018Cantor FitzgeraldReiteratesRadius Health (RDUS)Buy $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesAurinia Pharmaceuticals (AUPH)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetArsanis (ASNS)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $69.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesWorldpay (WP)Buy $92.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesbluebird bio (BLUE)Sell $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetArray Biopharma (ARRY)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetBellicum Pharmaceuticals (BLCM)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesSabra Health Care REIT (SBRA)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetProgenics Pharmaceuticals (PGNX)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetHorizon Pharma (HZNP)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetPolarityte (COOL)Buy $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesNeos Therapeutics (NEOS)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetParatek Pharmaceuticals (PRTK)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldRaises TargetGartner (IT)Overweight $148.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesEPAM Systems (EPAM)Buy $139.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesAimmune Therapeutics (AIMT)Buy $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetRevance Therapeutics (RVNC)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetAerie Pharmaceuticals (AERI)Buy $86.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetTheravance Biopharma (TBPH)Buy $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldInitiatesCaretrust REIT (CTRE)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesOPKO Health (OPK)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldUpgradesArrowhead Pharmaceuticals (ARWR)Neutral -> Overweight $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetNabriva Therapeutics (NBRV)Buy $16.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetOcular Therapeutix (OCUL)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetEndo International (ENDP)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesMallinckrodt (MNK)Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldDowngradesEgalet (EGLT)Overweight -> Hold $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetValeant Pharmaceuticals (VRX)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Hold $58.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)Hold $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesPhysicians Realty Trust (DOC)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesCross Country Healthcare (CCRN)Hold $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/5/2018Cantor FitzgeraldSet Price TargetCelgene (CELG)Hold $112.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Cantor FitzgeraldRaises TargetThe Ensign Group (ENSG)Overweight $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Cantor FitzgeraldDowngradesU.S. Physical Therapy (USPH)Overweight -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesAllscripts Healthcare Solutions (MDRX)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesU.S. Physical Therapy (USPH)Overweight -> Buy $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesMsci (MSCI)Buy $163.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldSet Price TargetVerastem (VSTM)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesMastercard (MA)Overweight $213.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Buy $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldReiteratesAAC (AAC)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Overweight -> Overweight$6.00 -> $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldReiteratesCommunity Health Systems (CYH)Hold $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldUpgradesAetna (AET)Neutral -> OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldLowers TargetAllergan (AGN)Neutral -> Neutral$191.00 -> $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldReiteratesAxoGen, Inc Common Stock (AXGN)Overweight -> Overweight$37.00 -> $45.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetMallinckrodt (MNK)Buy $42.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldReiteratesJazz Pharmaceuticals (JAZZ)Buy $202.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Overweight -> Buy$100.00 -> $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $191.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Cantor FitzgeraldSet Price TargetSeattle Genetics (SGEN)Hold $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018Cantor FitzgeraldReiteratesStryker (SYK)Hold -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Cantor FitzgeraldReiteratesBiogen (BIIB)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesEvolus (EOLS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesAccenture (ACN)Buy $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesAnthem (ANTM)Buy $275.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetCytokinetics (CYTK)Hold $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldReiteratesProthena (PRTA)Overweight -> Overweight$69.00 -> $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Cantor FitzgeraldReiteratesTivity Health (TVTY)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Cantor FitzgeraldReiteratesHumana (HUM)Hold $250.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/22/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/20/2018Cantor FitzgeraldReiteratesExponent (EXPO)Buy $24.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018Cantor FitzgeraldRaises TargetGW Pharmaceuticals (GWPH)Overweight -> Overweight$192.00 -> $205.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018Cantor FitzgeraldReiteratesSyntel (SYNT)Hold -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Cantor FitzgeraldRaises TargetUnitedHealth Group (UNH)Overweight $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Cantor FitzgeraldRaises TargetIntuitive Surgical (ISRG)Overweight $510.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldSet Price TargetGW Pharmaceuticals (GWPH)Buy $192.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldDowngradesCelldex Therapeutics (CLDX)Overweight -> Neutral $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/15/2018Cantor FitzgeraldSet Price TargetHorizon Pharma (HZNP)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Cantor FitzgeraldReiteratesCoupa Software (COUP)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $191.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Cantor FitzgeraldReiteratesBellicum Pharmaceuticals (BLCM)Overweight -> Overweight$10.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018Cantor FitzgeraldReiteratesExela Technologies (XELA)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Monday at 02:19 PM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  0.0 out of 5 (star star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  10,122 (Vote Underperform)
Total Votes:  10,122
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.